Marie Thibault
Stock Analyst at BTIG
(3.95)
# 625
Out of 5,131 analysts
104
Total ratings
55.67%
Success rate
9.88%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Reiterates: Buy | $88 | $82.92 | +6.13% | 4 | Jan 9, 2026 | |
| OM Outset Medical | Reiterates: Buy | $17 | $5.57 | +205.21% | 2 | Dec 16, 2025 | |
| CBLL CeriBell | Reiterates: Buy | $30 | $23.43 | +28.04% | 1 | Dec 15, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $100 → $103 | $83.01 | +24.08% | 2 | Dec 5, 2025 | |
| MASI Masimo | Maintains: Buy | $198 → $200 | $132.27 | +51.21% | 7 | Dec 4, 2025 | |
| BSX Boston Scientific | Reiterates: Buy | $132 | $95.72 | +37.90% | 14 | Nov 21, 2025 | |
| PODD Insulet | Maintains: Buy | $370 → $380 | $278.55 | +36.42% | 6 | Nov 21, 2025 | |
| ABT Abbott Laboratories | Reiterates: Buy | $145 | $124.64 | +16.34% | 14 | Nov 20, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $32 | $23.38 | +36.87% | 1 | Nov 18, 2025 | |
| ARAY Accuray | Maintains: Buy | $5 → $4 | $0.87 | +358.93% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $10.29 | +123.52% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $85 | $70.98 | +19.75% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $215 | $168.99 | +27.23% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.14 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $12.85 | +94.55% | 3 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.66 | - | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $58 → $52 | $37.64 | +38.15% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $65 | $66.76 | -2.64% | 8 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.88 | - | 2 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.52 | - | 3 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.98 | - | 3 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.11 | - | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $344.53 | -98.26% | 1 | Apr 9, 2020 |
Haemonetics
Jan 9, 2026
Reiterates: Buy
Price Target: $88
Current: $82.92
Upside: +6.13%
Outset Medical
Dec 16, 2025
Reiterates: Buy
Price Target: $17
Current: $5.57
Upside: +205.21%
CeriBell
Dec 15, 2025
Reiterates: Buy
Price Target: $30
Current: $23.43
Upside: +28.04%
Edwards Lifesciences
Dec 5, 2025
Maintains: Buy
Price Target: $100 → $103
Current: $83.01
Upside: +24.08%
Masimo
Dec 4, 2025
Maintains: Buy
Price Target: $198 → $200
Current: $132.27
Upside: +51.21%
Boston Scientific
Nov 21, 2025
Reiterates: Buy
Price Target: $132
Current: $95.72
Upside: +37.90%
Insulet
Nov 21, 2025
Maintains: Buy
Price Target: $370 → $380
Current: $278.55
Upside: +36.42%
Abbott Laboratories
Nov 20, 2025
Reiterates: Buy
Price Target: $145
Current: $124.64
Upside: +16.34%
Kestra Medical Technologies
Nov 18, 2025
Initiates: Buy
Price Target: $32
Current: $23.38
Upside: +36.87%
Accuray
Nov 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.87
Upside: +358.93%
Nov 4, 2025
Reiterates: Buy
Price Target: $23
Current: $10.29
Upside: +123.52%
Oct 31, 2025
Maintains: Buy
Price Target: $109 → $85
Current: $70.98
Upside: +19.75%
Oct 31, 2025
Maintains: Buy
Price Target: $195 → $215
Current: $168.99
Upside: +27.23%
Oct 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.14
Upside: -
Sep 5, 2025
Reiterates: Buy
Price Target: $25
Current: $12.85
Upside: +94.55%
Aug 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.66
Upside: -
Apr 30, 2025
Maintains: Buy
Price Target: $58 → $52
Current: $37.64
Upside: +38.15%
Oct 14, 2024
Maintains: Buy
Price Target: $62 → $65
Current: $66.76
Upside: -2.64%
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.88
Upside: -
Oct 6, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.52
Upside: -
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.98
Upside: -
Jan 21, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.11
Upside: -
Apr 9, 2020
Maintains: Buy
Price Target: $11 → $6
Current: $344.53
Upside: -98.26%